Liquidia Corp (LQDA): Next-Year EPS Estimate 80.63%

As of 2026-08-13, Liquidia Corp (LQDA) has a next-year EPS growth estimate of 80.63%. Featured in 4 EPS revision reports, most recently on 2026-05-19.

Latest revision: 80.53% → 80.63%
Revised on 2026-08-13

On 2026-08-13, analyst consensus for LQDA's next-year EPS growth shifted from 80.53% to 80.63% — a positive change of 0.10 percentage points. Current-year growth is projected at 492.22%.

What's Driving This

LQDA’s rise is driven primarily by a structural uptrend in analyst expectations: on 2026-07-23, consensus next-year EPS growth estimates were raised from 71.77% to 76.85%, and have since climbed further to 80.63% over two sessions of consistent upward revision. No recent headlines explicitly link to the move, so the catalyst is likely an unannounced fundamental reassessment, such as an internal guidance raise or product traction. The continued momentum beyond the initial revision confirms sustained analyst confidence rather than a one-off reaction.

Generated 2026-08-13 from news as of 2026-08-13

Current Snapshot

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
EPS growth next year
80.63%
EPS growth this year
492.22%
EPS next quarter (est)
$0.90
Last price
$76.73

EPS Revision History

80.6%71.8%07-1407-2107-2908-0508-13
Next-year EPS growth estimate · latest 30 days · 27 observations
591.4%572.9%07-1407-2107-2908-0508-13
Combined EPS growth (this year + next year) · latest 30 days · 27 observations
DateEPS Next YEPS This YNext Q (est)Price
2026-08-1380.63%492.22%$0.90$76.73
2026-08-1280.53%499.03%$0.88$78.79
2026-08-1176.85%514.50%$0.76$88.05
2026-08-1076.85%514.50%$0.76$91.03
2026-08-0976.85%514.50%$0.76$90.22
2026-08-0776.85%514.50%$0.76$90.22
2026-08-0676.85%514.50%$0.76$89.42
2026-08-0576.85%514.50%$0.76$89.12
2026-08-0476.85%514.50%$0.76$88.38
2026-08-0376.85%514.50%$0.76$83.85
2026-08-0276.85%514.50%$0.76$84.11
2026-07-3176.85%514.50%$0.76$84.11
2026-07-3076.85%514.50%$0.76$86.80
2026-07-2976.85%514.50%$0.76$86.82
2026-07-2876.85%514.50%$0.76$86.82
2026-07-2776.85%514.50%$0.76$84.42
2026-07-2676.85%514.50%$0.76$86.22
2026-07-2476.85%514.50%$0.76$86.22
2026-07-2376.85%514.50%$0.76$89.03
2026-07-2271.77%514.50%$0.76$87.04
2026-07-2171.77%514.50%$0.76$80.89
2026-07-2071.77%514.50%$0.76$77.08
2026-07-1971.77%514.50%$0.76$79.94
2026-07-1771.77%514.50%$0.76$79.94
2026-07-1671.77%514.50%$0.76$75.27
2026-07-1571.77%514.50%$0.76$77.75
2026-07-1471.77%514.50%$0.76$76.49
2026-07-1371.77%514.50%$0.76$71.21
2026-07-1271.77%514.50%$0.76$77.93
2026-07-0971.77%514.50%$0.76$81.45

Reports Featuring LQDA

Screen Performance

Aggregate stats across all 1969 tickers our top-EPS-revision screen has flagged over the past 134 days.

Median return since detection
+4.2%
% of tickers in the green
58%
Median return on winners
+21.7%
Large revisions captured
1458

Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.

Also Tracked by Our Screen

Frequently Asked Questions

What is Liquidia Corp's next-year EPS growth estimate?

As of 2026-08-13, Liquidia Corp (LQDA) has a next-year EPS growth estimate of 80.63%, based on analyst consensus.

When was the latest EPS estimate revision for LQDA?

The most recent revision occurred on 2026-08-13, when analysts adjusted the next-year EPS growth estimate from 80.53% to 80.63%.

What sector and industry does Liquidia Corp belong to?

Liquidia Corp operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.

How often is this EPS estimate data updated?

EPS revision data is refreshed daily from analyst consensus estimates. LQDA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.

EPS revision data sourced from analyst consensus estimates, refreshed daily. Liquidia Corp (LQDA) appears here because it was detected by our daily top-EPS-revision-performer screen.